Discounted Cash Flow
Prestige Consumer Healthcare Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2017 | $882.1m | $69.4m | $144.8m | 7.9% | $1.31 |
| 2018 | $1.0b (18.0%) | $339.6m (389.3%) | $197.6m (36.5%) | 32.6% (314.5%) | $6.40 (388.5%) |
| 2019 | $975.8m (-6.3%) | $-35.8m (-110.5%) | $178.8m (-9.5%) | -3.7% (-111.2%) | $-0.69 (-110.8%) |
| 2020 | $963.0m (-1.3%) | $142.3m (497.4%) | $202.6m (13.3%) | 14.8% (502.7%) | $2.81 (507.2%) |
| 2021 | $943.4m (-2.0%) | $164.7m (15.7%) | $213.4m (5.3%) | 17.5% (18.2%) | $3.28 (16.7%) |
| 2022 | $1.1b (15.2%) | $205.4m (24.7%) | $250.3m (17.3%) | 18.9% (8.3%) | $4.09 (24.7%) |
| 2023 | $1.1b (3.8%) | $-82.3m (-140.1%) | $221.9m (-11.3%) | -7.3% (-138.6%) | $-1.65 (-140.3%) |
| 2024 | $1.1b (-0.2%) | $209.3m (354.3%) | $239.4m (7.9%) | 18.6% (354.9%) | $4.21 (355.2%) |
| 2025 | $1.1b (1.1%) | $214.6m (2.5%) | $243.3m (1.6%) | 18.9% (1.4%) | $4.32 (2.6%) |
| 2026 | $1.1b (-4.3%) | $190.3m (-11.3%) | $246.4m (1.3%) | 17.5% (-7.3%) | $3.93 (-9.0%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.